These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22354545)

  • 41. Selenium supplementation in thyroid eye disease: an updated review from a clinical ophthalmic perspective.
    Foos W; Maliakkal Hernandez J; Mansour TN
    Orbit; 2023 Nov; ():1-11. PubMed ID: 37976183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graves' ophthalmopathy: natural history and treatment outcomes.
    Noth D; Gebauer M; Müller B; Bürgi U; Diem P
    Swiss Med Wkly; 2001 Oct; 131(41-42):603-9. PubMed ID: 11820071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extrathyroidal manifestations of Graves' disease: a 2014 update.
    Bartalena L; Fatourechi V
    J Endocrinol Invest; 2014 Aug; 37(8):691-700. PubMed ID: 24913238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Graves' orbitopathy: imperfect treatments for a rare disease.
    Bartalena L
    Eur Thyroid J; 2013 Dec; 2(4):259-69. PubMed ID: 24783057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of thyroid eye disease in Graves' disease: A meta-analysis and systematic review.
    Chin YH; Ng CH; Lee MH; Koh JWH; Kiew J; Yang SP; Sundar G; Khoo CM
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):363-374. PubMed ID: 32691849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease.
    Strianese D
    Curr Opin Ophthalmol; 2017 Sep; 28(5):505-513. PubMed ID: 28700384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug safety in thyroid eye disease - a systematic review.
    Wolf J; Mitka KI; Hubalewska-Dydejczyk A; Krämer I; Kahaly GJ
    Expert Opin Drug Saf; 2022 Jul; 21(7):881-912. PubMed ID: 35447047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Managing acute and recurrent idiopathic pericarditis.
    Schwier NC; Cornelio CK; Epperson TM
    JAAPA; 2020 Jan; 33(1):16-22. PubMed ID: 31880644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of acute Graves orbitopathy.
    Kazim M; Trokel S; Moore S
    Ophthalmology; 1991 Sep; 98(9):1443-8. PubMed ID: 1945322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Management of Graves' ophthalmopathy].
    Schalin-Jäntti C
    Duodecim; 2010; 126(20):2431-7. PubMed ID: 21125757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease.
    Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ
    Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Teprotumumab: A Review in Thyroid Eye Disease.
    Nie T; Lamb YN
    Drugs; 2022 Nov; 82(17):1663-1670. PubMed ID: 36418673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
    J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of patients in a combined thyroid eye clinic in secondary care.
    Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
    Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Results of 3-stage treatment: (I) corticotherapy, (II) linear acceleration and (III) orbital decompression in 206 patients with malignant Graves ophthalmopathy].
    Zgliczyński S; Jastrzebska H; Górowski T; Janik J; Kuś J; Hliniak A; Karczmarzyk R; Kukołowicz P
    Endokrynol Pol; 1992; 43(3):274-86. PubMed ID: 1345567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid eye disease: what is new to know?
    Li Z; Cestari DM; Fortin E
    Curr Opin Ophthalmol; 2018 Nov; 29(6):528-534. PubMed ID: 30124533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review.
    Ismailova DS; Belovalova IM; Grusha YO; Sviridenko NY
    Int Med Case Rep J; 2018; 11():243-249. PubMed ID: 30319289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
    Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute and Recurrent Pericarditis.
    Imazio M; Gaita F
    Cardiol Clin; 2017 Nov; 35(4):505-513. PubMed ID: 29025542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of Graves' ophthalmopathy: reality and perspectives.
    Bartalena L; Pinchera A; Marcocci C
    Endocr Rev; 2000 Apr; 21(2):168-99. PubMed ID: 10782363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.